SFN and metastatic malignant neoplasm: In particular, SFN immunoreactivity scores within the stroma of normal breast tissue were significantly lower than the SFN immunoreactivity scores within stroma of primary (p < 0.05) and metastatic cancer tissues (p < 0.001).